For the Inventor, By the Inventor

Enter inventor name

Burlingame, CA, United States of America

Andrei William Konradi

USPTO Granted Patents = 88 (Patent Applications = 21)

CIPO Patents = 3 (Patent Applications = 19)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 5.1

ph-index = 14

Forward Citations = 513(Granted Patents)

Forward Citations (Not Self Cited) = 245(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Francisco, CA (US) (2001 - 2010)
Burlingame, CA (US) (2006 - 2024)

Company Filing History:

Elan Pharmaceuticals, Inc.

24 out of 1,309

Cortexyme, Inc.

Vivace Therapeutics, Inc.

Cytomx Therapeutics, Inc.

Algen Biotechnologies, Inc.

Imago Pharmaceuticals, Inc.

Lighthouse Pharmaceuticals, Inc.

Amplyx Pharmaceuticals, Inc.

Concentric Analgesics, Inc.

11. 13 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Chemical Compositions

Ketone Inhibitors

Bicyclic Compounds

Activatable Antibodies

Pyridine Derivatives

Oxadiazole Compounds

VLA-4 Antagonists

Leukocyte Adhesion Inhibitors

Polymer Conjugates

TRPV1 Agonists

Jun N-terminal Kinase Inhibitors

Rheumatoid Arthritis Treatments

88 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264152 - Certain chemical compositions and methods of use thereof (2025-04-01),

2. 12110263 - Ketone inhibitors of lysine gingipain (2024-10-08),

3. 12103902 - Bicyclic compounds (2024-10-01),

4. 11992528 - Compositions and methods for conjugating activatable antibodies (2024-05-28),

5. 11866431 - Bicyclic compounds (2024-01-09),

6. 11771688 - Pyridine derivatives substituted by heterocyclic ring and amino group (2023-10-03),

7. 11661403 - Oxadiazole compounds (2023-05-30),

8. 11591322 - Certain chemical compositions and methods of use thereof (2023-02-28),

9. 11524943 - Benzocarbonyl compounds (2022-12-13),

10. 11420935 - Bicyclic compounds (2022-08-23),

11. 11332464 - Inhibitors of lysine gingipain (2022-05-17),

12. 11325884 - Ketone inhibitors of lysine gingipain (2022-05-10),

13. 11192865 - Benzosulfonyl compounds (2021-12-07),

14. 11186554 - Non-fused tricyclic compounds (2021-11-30),

15. 11059786 - Aminopyridine compounds and methods for the preparation and use thereof (2021-07-13),

Of course! Here is the article about inventor Andrei William Konradi:

Title: The Innovations of Andrei William Konradi

Introduction:

Andrei William Konradi, a talented inventor based in Burlingame, CA (US), has made significant contributions to the field of pharmaceuticals with his numerous patented inventions. With 83 patents to his name, Konradi is a pioneering figure in the realm of medical research and innovation.

Latest Patents:

Among his latest patented inventions are groundbreaking compounds aimed at treating cancers mediated by YAP/TAZ and fungal diseases. The first patent focuses on bicyclic compounds that target cancers influenced by the YAP/TAZ pathway, offering a promising avenue for therapeutic intervention. The second patent introduces pyridine derivatives with potent antifungal properties, presenting new possibilities for combating fungal diseases and infections.

Career Highlights:

Konradi's exceptional career includes notable stints at Elan Pharmaceuticals, Inc. and Wyeth, where he has honed his expertise in pharmaceutical research and development. His innovative approach to drug discovery has led to the creation of groundbreaking compounds that have the potential to revolutionize cancer and antifungal treatments.

Collaborations:

Throughout his career, Konradi has collaborated with accomplished professionals in the field of pharmaceuticals. Notable individuals such as Christopher Michael Semko and Michael A. Pleiss have worked alongside Konradi, contributing their expertise to the development of novel pharmaceutical compounds.

Conclusion:

In conclusion, Andrei William Konradi stands out as a prolific inventor in the realm of pharmaceuticals, with a remarkable track record of 83 patents to his name. His innovative compounds targeting cancers and fungal diseases showcase his dedication to advancing medical research and improving patient outcomes. Konradi's collaborations with esteemed colleagues further underscore his commitment to fostering innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…